Evidence map›Paper›PMID 31540207›Full record

ArticleCells2019

Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis.

Jesus Cosin-Roger, Francisco Canet, Dulce C Macias-Ceja, Laura Gisbert-Ferrándiz, Dolores Ortiz-Masiá, Juan V Esplugues, Rafael Alós, Francisco Navarro, María D Barrachina, Sara Calatayud

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jesus Cosin-RogerHospital Dr Peset, FISABIO, 46017 Valencia, Spain.
Francisco CanetDepartamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.
Dulce C Macias-CejaDepartamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.
Laura Gisbert-FerrándizDepartamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2007-8716
Dolores Ortiz-MasiáCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, 46010 Valencia, Spain.
Juan V EspluguesHospital Dr Peset, FISABIO, 46017 Valencia, Spain.
Rafael AlósDepartamento de Cirugía del Aparato Digestivo, Hospital La Fe, 46526 Valencia, Spain.
Francisco NavarroDepartamento de Cirugía y Coloproctología, Hospital de Manises, 46940 Valencia, Spain.ORCID 0000-0002-9775-3169
María D BarrachinaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, 46010 Valencia, Spain. dolores.barrachina@uv.es.
Sara CalatayudCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, 46010 Valencia, Spain.ORCID 0000-0001-9675-2423
Universitat de València · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital de Manises · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently observed reduced autophagy in Crohn's disease patients and an anti-inflammatory effect of autophagy stimulation in murine colitis, but both anti- and pro-fibrotic effects are associated with autophagy stimulation in different tissues, and fibrosis is a frequent complication of Crohn's disease. Thus, we analyzed the effects of pharmacological modulation of autophagy in a murine model of intestinal fibrosis and detected that autophagy inhibition aggravates, while autophagy stimulation prevents, fibrosis. These effects are associated with changes in inflammation and in collagen degradation in primary fibroblasts. Thus, pharmacological stimulation of autophagy may be useful against intestinal fibrosis.

Indexed as

AnimalsAutophagyCollagenCrohn DiseaseDisease Models, AnimalFibroblastsFibrosisImmunosuppressive AgentsInflammationIntestinesMiceMice, Inbred C57BLSirolimusCollagenImmunosuppressive AgentsSirolimusautophagyinflammationintestinal fibrosis

Identifiers

PMID31540207
PMCPMC6770118
OpenAlexW2973226917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.